Yuksel Murat, Yildiz Abdulkadir, Tekbas Ebru, Gunduz Ercan, Ekinci Aysun, Bilik Mehmet Zihni, Ozaydogdu Necdet, Atilgan Zuhal
From the Cardiology Department (MY, AY, ET, MZB, NO, ZA); Internal Medicine/Division of Emergency (EG); and Biochemistry Department, Dicle University School of Medicine, Diyarbakir, Turkey (AE).
Medicine (Baltimore). 2015 May;94(17):e786. doi: 10.1097/MD.0000000000000786.
Paraoxonase-1, a high-density lipoprotein linked enzyme complex, was shown to be decreased in several cardiovascular diseases. We aimed to explore whether serum paraoxonase and arylesterase activities differ in dipper and non-dipper prehypertensive subjects compared to healthy controls.Sixty prehypertensive subjects and 30 controls were enrolled. All subjects underwent echocardiographic assessment and 24-hour ambulatory blood pressure monitoring (ABPM). According to the blood pressure (BP) course on ABPM, prehypertensive subjects were categorized into two: non-dipper prehypertensive (NDPH) and dipper prehypertensive (DPH) groups. Serum paraoxonase and arylesterase activities were detected spectrophotometrically.Paraoxonase and arylesterase activities were significantly lower in patients with NDPH compared to both DPH and control groups. Both paraoxonase and arylesterase activities showed significant negative correlations with BP and left ventricular mass index.We have demonstrated that NDPH subjects have lower paraoxonase and arylesterase activities compared to DPH subjects and normotensives. Further prospective studies are needed to clarify the role of paraoxonase and arylesterase activities in the development of overt hypertension in prehypertensive subjects.
对氧磷酶-1是一种与高密度脂蛋白相关的酶复合物,在几种心血管疾病中其水平会降低。我们旨在探究与健康对照相比,血压正常高值的杓型和非杓型受试者的血清对氧磷酶和芳基酯酶活性是否存在差异。招募了60名血压正常高值的受试者和30名对照。所有受试者均接受了超声心动图评估和24小时动态血压监测(ABPM)。根据ABPM的血压(BP)变化过程,将血压正常高值的受试者分为两组:非杓型血压正常高值(NDPH)组和杓型血压正常高值(DPH)组。采用分光光度法检测血清对氧磷酶和芳基酯酶活性。与DPH组和对照组相比,NDPH组患者的对氧磷酶和芳基酯酶活性显著降低。对氧磷酶和芳基酯酶活性均与血压和左心室质量指数呈显著负相关。我们已经证明,与DPH受试者和血压正常者相比,NDPH受试者的对氧磷酶和芳基酯酶活性较低。需要进一步的前瞻性研究来阐明对氧磷酶和芳基酯酶活性在血压正常高值受试者发生显性高血压过程中的作用。